Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical

Affiliations

• ¹ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital (CHUV, Centre Hospitalier Universitaire Vaudois), Lausanne, Switzerland. Electronic address: christina.orasch@hirslanden.ch.
• ² Pediatric Infectious Diseases Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
• ³ Division of Infectious Diseases, University of Genova (DISSAL), IRCCS San Martino-IST, Genoa, Italy.
• ⁴ APHP-Henri Mondor Hospital, Hematology Department and Université Paris Est-Créteil, Paris, France.
• ⁵ Norwich Medical School, University of East Angila, Norwich, United Kingdom.
• ⁶ Department of Internal Medicine, Radboud University Medical Center, The Netherlands; Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands; Hasselt University, Hasselt, Belgium.
• ⁷ National Research Center for Hematology, Moscow, Russia.
• ⁸ Center for Infectious Diseases and Travel Medicine, Department of Medicine, University Hospital, Albert-Ludwigs University, Freiburg, Germany.
• ⁹ Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
• ¹⁰ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital (CHUV, Centre Hospitalier Universitaire Vaudois), Lausanne, Switzerland.